aripiprazole has been researched along with Torsade de Pointes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graff, C; Kanters, JK; Meyer, J; Nielsen, J; Polcwiartek, C; Sneider, B; Taylor, D | 1 |
| Khan, A; Kneale, B | 1 |
| Bauer, LK; Januzzi, JL; Leskov, I; Mukherji, EH; Tanev, KS | 1 |
| Leung, JG; Nelson, S | 1 |
| Citrome, L; Volavka, J | 1 |
2 review(s) available for aripiprazole and Torsade de Pointes
| Article | Year |
|---|---|
The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Death, Sudden, Cardiac; Electrocardiography; Heart; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Potassium; Risk Factors; Safety; Torsades de Pointes | 2015 |
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain | 2004 |
3 other study(ies) available for aripiprazole and Torsade de Pointes
| Article | Year |
|---|---|
Life threatening torsades de pointes due to abiraterone-induced hypokaelemia in a patient with metastatic prostate cancer.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Drug-Related Side Effects and Adverse Reactions; Humans; Long QT Syndrome; Male; Prostatic Neoplasms; Torsades de Pointes | 2016 |
Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bundle-Branch Block; Combined Modality Therapy; Cooperative Behavior; Electrocardiography; Electroconvulsive Therapy; Female; Haloperidol; Humans; Interdisciplinary Communication; Long QT Syndrome; Piperazines; Quinolones; Risk Factors; Torsades de Pointes | 2011 |
Torsades de pointes after administration of low-dose aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetes Complications; Drug Monitoring; Heart Arrest; Humans; Hypertension; Male; Piperazines; Quinolones; Risk Factors; Schizophrenia; Stroke; Torsades de Pointes; Treatment Outcome | 2013 |